Markers in Follicular Fluid and in Embryo Culture Medium as a Marker of Oocyte and Embryo Quality
NCT ID: NCT03350009
Last Updated: 2019-01-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
220 participants
OBSERVATIONAL
2017-12-11
2019-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Aim of the Study is to Check Whether Follicular Fluid Evaluation Using a Spectrophotometer Can Differentiate High Quality Oocytes From Low Quality Oocytes. Oocyte Quality Will be Defined Using GDF9, BMP15 and Oocyte Morphology.
NCT07329998
Human Follicular Fluid Markers and Reproductive Outcomes in IVF
NCT05893238
Novel Evaluation of Aspirated Follicular Fluid
NCT02999555
In Vitro Maturation of Immature Oocytes
NCT00480337
Assessment of Myeloid Cell Constitution in the Follicular Fluid of Women Undergoing In-vitro Fertilization
NCT02342106
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
High and low grade embryos
The distribution for the high and low grade embryos is based on common morphological grading criteria.
No interventions assigned to this group
High and low quality follicles
The distribution for the high and low grade oocytes is based on common morphological grading criteria and on different features of the participants such as age.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Female patients age 18-45
Exclusion Criteria
* Patient's request to be withdrawn from the study.
18 Years
45 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Carmel Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Martha Direnfeld, Prof.
Role: PRINCIPAL_INVESTIGATOR
Carmel Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Carmel Medical Center
Haifa, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CMC-16-0163-CTIL
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.